Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | The promise of gene therapy for the treatment of SCPCD

In this video, Leonardo Brandão, MD, MSc, The Hospital for Sick Children, University of Toronto, Toronto, Canada, discusses the promising potential of gene therapy for the treatment of severe congenital protein C deficiency (SCPCD). This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

Disclosures

Past co-chair of ISTH
Co-chair of SCPCD Registry sponsored by Takeda

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.